Last reviewed · How we verify

NCT05248178

tDCS and Metacognitive Strategy Training in Stroke

Terminated NA Last updated 15 June 2025
What this trial tests

NA trial testing CO-OP Procedures in Chronic Stroke in 11 participants. Terminated before completion.

Timeline
31 January 2022
Primary endpoint
11 June 2025
11 June 2025

Quick facts

Lead sponsorUniversity of Missouri-Columbia
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment11
Start date31 January 2022
Primary completion11 June 2025
Estimated completion11 June 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Missouri-Columbia

Who can join

Adults 18 to 85, any sex, with Chronic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Specific Aim 1: Complete pilot testing of study protocol in individuals with chronic stroke for feasibility evaluation and protocol refinement. Specific Aim 2: Estimate the preliminary effect of CO-OP+tDCS on activity performance in individuals with chronic stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of CO-OP Procedures

Trials testing the same drug.

Other recruiting trials for Chronic Stroke

Currently open trials in the same condition.

Other University of Missouri-Columbia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05248178.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing